04 May 2007
Elevated antibody response by antigen presentation in immune complexes
Arpad Zsigmond Barabas, Chad Douglas Cole, Zoltan Bernat Kovacs, Rene LafreniereMed Sci Monit 2007; 13(5): BR119-124 :: ID: 484593
Abstract
Background: Active immunization techniques against exogenous source antigens (ags – such as bacteria, virus) proved to be successful in preventing many acute infectious diseases from occurring in a susceptible
population. However, an active immunization technique that could be employed both prophylactically and therapeutically has so far not been described. We have developed a new vaccination technique that employs specifi c immune complex (IC) containing components which is able to redirect immune-response outcomes in both preventative and curative regimens in an experimental
autoimmune kidney disease. The technique with appropriate modifi cations was assessed using an exogenous ag in our present experiment.
Material/Methods: We prepared an exogenous ag on a HiTrap™ affi nity column and injected it by fi ve different vaccination techniques into rats. Antibody (ab) responses against the ag were evaluated by ELISA. Statistical analysis assessed possible signifi cant differences in ab responses.
Results: The most powerful immune response was initiated following intraperitoneal (IP) injections of normal rabbit immunoglobulin G (nRIgG) in Freund’s complete adjuvant (FCA). The second most powerful immune response was evoked when the same ag (nRIgG) was injected in the form of IC at ag excess.
Conclusions: 1. Induction of a powerful ab response, without the use of an adjuvant, can be achieved in rats injected with ICs.
2. IC is non-toxic, non-irritant, and able to initiate the production of the same class of immunoglobulin with the same specifi city/function that resides in the inoculum.
Keywords: Antigen Presentation, Antibody Formation, Antigen-Antibody Complex, Enzyme-Linked Immunosorbent Assay, Immunoglobulin G - immunology, Vaccination
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
11 Mar 2024 : Clinical Research
Enhancement of Frozen-Thawed Human Sperm Quality with Zinc as a Cryoprotective AdditiveMed Sci Monit In Press; DOI: 10.12659/MSM.942946
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952